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Abstract.  A  58-kD cis-Golgi protein has been iden- 
tiffed by generating polyclonal antibodies against heavy 
(cis)  Golgi subfractions.  Total  microsomes isolated 
from rat pancreatic homogenates were subfractionated 
to yield a rough microsomal fraction (B1) and three 
smooth membrane subfractions (B2-B4) enriched in 
cis-,  middle,  and trans-Golgi elements,  respectively. 
The heavy (cis) subfraction,  B2 (d  --  1.17 g/rrd), 
was fractionated by Triton Xo114 phase separation,  and 
the proteins recovered in the detergent phase were 
used to immunize rabbits.  One of the anti-B2 antibod- 
ies obtained gave a "Golgi'-'staining  pattern when 
screened by immunofluorescence on normal rat kidney 
cells and mouse RPC 5.4 myeloma cells. In rat pan- 
creatic exocrine cells the antibody reacted with the 
plasmalemma as well as elements in the Golgi region. 
By immunoelectron microscopy, the antigen recog- 
nized by anti-B2 IgG was found to be restricted to cis- 
Golgi elements in myeloma cells where it was concen- 
trated in the fenestrated cis-most cisterna and in some 
of the tubules and vesicles located along the cis face 
of the Golgi complex. By immunoprecipitation and 
immunoblotting,  the anti-B2 IgG exclusively recog- 
nized a 58-kD protein in myeloma cells. The anti-B2 
IgG reacted with several proteins in solubilized pan- 
creatic B2 membranes,  including a 58-kD protein, but 
affinity-purified anti-58-kD IgG reacted exclusively 
with the 58-kD protein.  These results suggest that the 
58-kD protein is a  specific component of cis-Golgi 
membranes. 
T 
HERE is  now widespread agreement that  the Golgi 
complex consists  of a series of distinct  subcompart- 
ments arranged  in polarized series (reviewed in refer- 
ence  ll).  According  to the prevailing  stationary  cisternae 
model, each Golgi cisterna or set of cisternae  is assumed to 
represent a separate subcompartment with a distinctive mem- 
brane composition. Protein and lipid substrates are assumed 
to move sequentially  across the Golgi stack and to be pro- 
gressively modified in transit  by resident Golgi enzymes. 
The exact number of Golgi subcompartments is still unknown. 
Three subcompartments  have been defined, cis, middle,  and 
trans, based on the location in Golgi subfractions  of early, 
intermediate,  and late-acting  Golgi enzyme activities  (1, 7, 
8,  10,  16), but morphologic and cytochemical  findings sug- 
gest that there may be many  more than three (11, 12). Al- 
though  many  enzyme activities  have been ascribed to the 
Golgi complex, the number of resident Golgi proteins that 
have been purified  and localized in situ  is limited  to two 
trans-Golgi markers,  galactosyl-  (28) and sialyltransferase 
(29), and two middle Golgi markers,  N-acetylglucosaminyl- 
transferase  I (9) and r  II (24).  So far no cis- 
Golgi resident protein  has been purified  and localized. 
Recently we succeeded in preparing  subfractions enriched 
in cis (heavy), middle (intermediate),  and trans (light) Golgi 
elements  based on the distribution  of enzyme and kinetic 
markers (32) from rat pancreatic  microsomes. The fact that 
the heaviest (B2) Golgi subfraction  was well separated from 
trans-Golgi elements marked by galactosyltransferase  activ- 
ity suggested  that  this  fraction  might  represent a  suitable 
starting  material  to attempt  to generate  antibodies  against 
cis-Golgi membrane proteins.  The overall strategy  that we 
devised (31) is as follows. (Step 1 ) Prepare heavy (d =  1.17 
g/ml) Golgi subfractions from the rat pancreas as done previ- 
ously (32)  and  separate  (by Triton  X-114 phase-separation 
[3]) hydrophobic membrane proteins from hydrophilic mem- 
brane or secretory proteins (3, 27). (Step 2) Use the fractions 
enriched  in hydrophobic  membrane proteins to immunize 
rabbits. (Step 3) Screen for widely distributed Golgi antigens 
by immunofluorescence  on several,  nonpancreas  cell types. 
(Step 4) Determine by immunoelectron microscopy the loca- 
tion  within  the Golgi complex of the Golgi-specific  anti- 
gen(s). (Step 5) Characterize  by immunoblotting  and immu- 
noprecipitation  any cis-Golgi-specific  antigens  recognized. 
Here we report that with this strategy we have identified 
a 58-kD protein that appears to represent a specific marker 
for the cis-Golgi cisternae. 
Materials and Methods 
Materials 
Reagents and supplies were obtained from the following sources: [35S]me- 
thionine (1,375 IxCi/mmol) and [35S]cysteine (>600 ~tCi/rnmol) from Amer- 
sham Corp. (Arlington Heights, IL); ~25I-Na (14.8 mCi/l~g) and ~25I-protein 
A (2-10 ~tCi/~tg) from New England Nuclear (BosUn, MA); Autofluor from 
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Chemical Co. (Kansas City, MO). All cell culture media ~ere from Gibco 
(Grand  Island,  NY);  aprotinin was  from Boehringer Mannheim (Indi- 
anapolis, IN), and the Sephadex  G-25 columns (PD-10) from Pharmacia 
Fine Chemicals (Piscataway, N  J); phenylmethylsulphonyl  fluoride (PMSF), 
Tween-20,  Triton X-I14, protein A-Sepharose  CL-4B,  benzamidine hydro- 
chloride, diaminobenzidine, and anti-rabbit IgG coupled to alkaline phos- 
phatase were from Sigma Chemical Co. (St. Louis, MO). The BCIP/NBT 
substrate system  for alkaline phosphatase was  from Kirkegaard  &  Perry 
Laboratories,  Inc.  (Gaithersburg, MD),  and rhodamine-conjugated  goat 
anti-rabbit IgG and peroxidase-conjugated  sheep Fab fragments against rab- 
bit IgG were from Cooper Biomedical Inc. (Malvern, PA) and Biosys (Cam- 
pirgne,  France),  respectively.  Nitrocellulose  filters  (0.45-1xm-pore size) 
were purchased from Schleicher & Schuell, Inc., (Keene,  N  J), Aquaside 
II from Calbiocbem-Behring Corp. (San Diego,  CA), and SDS-PAGE re- 
agents from Bio-Rad  Laboratories (Richmond, CA). 
Male Sprague-Dawley  rats (150-180 g) and female New Zealand White 
rabbits ("~i.5 kg) were purchased from Camm Laboratory Animals (Wayne, 
N J) and Montowese  Rabbitry (Woodstock,  CT), respectively. 
Preparation of  Heavy Goigi Subfractions and 
Immunization of  Rabbits 
The procedure for the isolation  and subfractionation  of total microsomes 
(TM) ~ from  rat  pancreatic cell  homogenates  was  described previously 
(32).  Briefly, TM were subfractionated  by flotation  in a sucrose gradient 
yielding five bands (BI-B5) of decreasing density. BI contains 85% of the 
total protein and practically  all of the RNA and consists primarily of rough 
microsomes.  B2-B4 consist primarily of smooth vesicles (d =  1.17, 1.15, 
and 1.13  g/ml, respectively).  B2 represents the first post-endoplasmic  reticu- 
lum (ER) compartment reached by secretory proteins and their site of trans- 
port arrest at  I6~  (32).  B4  has the highest specific  activity  for galac- 
tosyltransferase,  a trans-Golgi marker.  B2 fractions were collected  from a 
total of 12 analytical sucrose gradients, diluted with an equal volume of 150 
mM NaCI,  10 mM Tris-HCI,  pH 7.4, containing 1t30 U/ml aprotinin and 
5 mM benzamidine, and concentrated by centrifugation at 100,000 gay for 
60 min at 3~  in a  SW41 rotor (Beckman Instruments, Inc., Palo Alto, 
CA). The pellet was resuspended (,~,500 Ixg/ml protein) in I ml of the above 
buffer (lacking protease  inhibitors) containing 0.5%  Triton X-114 and was 
incubated on ice for 15 min. Phase separation was carried out as described 
by Bordier (3). The detergent  phase was diluted with PBS to give a final 
detergent concentration of"-,0.5 %, then divided into aliquots, and stored at 
-80~ 
TWO rabbits were immunized with B2 membrane proteins (derived from 
the Triton X-114  detergent phase) according to the procedure of Lonvard et 
al. (21). Each rabbit received a total of ,',,300 ~tg B2 protein. Rabbits were 
bled at 2-wk intervals.  From the antisera obtained, referred to as anti-B2, 
IgG was prepared using a protein  A-Sepharose CL-4B column. 
Cell Culture and Biosynthetic Labeling 
Normal rat kidney (NRK) cells were grown in DME supplemented with 14.6 
mg/liter L-glutamine, 5 % FBS, penicillin (10,000 U/liter), and streptomycin 
(100 rag/liter), and were used at •50%  confluency. Mouse myeloma (RPC 
5.4) cells were grown in DME supplemented with nonessential amino acids 
containing 4,500 mg/liter glucose and 10 % FBS and penicillin/streptomycin 
as above, and harvested in the exponential  growth phase. 
For radiolabeling,  cells were incubated (30 rain at 37~  in methionine- 
free  medium  containing  10%  dialyzed  FBS  followed  by  incubation in 
[3~S]methionine (100 t.tCi/ml)  for 4-5  h.  After labeling,  the cells were 
washed and incubated for 15 rain on ice in 0.5 ml lysis buffer (150 mM NaCI, 
10 mM Tris, pH 7.4, containing 1% Triton X-100, 100 U/ml aprotinin, and 
1 mM PMSF). Lysates were cleared by centrifugation 01,500 g for 15 min 
in a microfuge),  and the supernatants were used for immunoprecipitation. 
Radioiodination of  Pancreatic  B2 Proteins 
B2 membrane proteins (100-200 gg) harvested from the detergent phase af- 
ter Triton X-114 separation were suspended in 0.5 ml of 0.1 M phosphate 
buffer, pH Z4, and radioiodinated  with 0.5 mCi tZSl-Na using Iodobeads 
according to the instructions of the manufacturer (Pierce Chemical Co.). 
After iodination (10 rain at 0~  the labeled proteins were separated  from 
1. Abbreviations used in this paper: ER, endoplasmic reticulum; NRK, nor- 
mal rat kidney;  TM, total microsomes. 
free ~25I by gel filtration  on a 9-ml PD-10 column equilibrated  with PBS 
containing 0.5%  Triton  X-100. 
Immunoprecipitation 
Aliquots (10 gtl) of radioiodinated  132 proteins or biosynthetically  labeled 
NRK or myeloma cell extracts were solubilized  in 1 ml NET buffer (400 
mM NaC1, 5 mM EDTA, 20 mM "Iris, pH 8.0, 1% Triton X-100, containing 
100 U/ml aprotinin and 1 mM PMSF), and cleared by incubation at 4~ 
in  I0 ~tl preimmune serum (overnight)  and protein A-Sepharose  CL-4B 
beads preswollen  in NET buffer  (60 rain). After centrifugation (30 s at 
11,500 g in a microfuge), 50 ~g anti-B2 IgG was added to the supernatants, 
incubated overnight, and bound to protein A-Sepharose.  The beads were 
washed five times with NET buffer and once with 10 mM Tris-HCI (pH 7.4). 
The precipitated  proteins were solubilized by boiling in SDS-PAGE sample 
buffer (3.65%  SDS,  18 mM dithiothreitol, 4.5 mM EDTA, 40 mM Tris- 
phosphate, pH 6.8, 10% glycerol) for 3 min and separated on 10% SDS-gels 
(22). The gels were soaked in Autofluor, dried, and exposed to preflashed 
Kodak X-Omat film. 
Preparation of TM  frora Myeloma Cells 
RPC 5.4 myeloma cells (5-8 ￿  l0  s) were swollen in 10 ml ice-cold  10 mM 
Tris (pH 7.4),  10 mM KCI,  1.5 mM MgCI2 for 5 min and then homoge- 
nized with five passes through a ball beating homogenizer (2). The homoge- 
nate was made 0.25 M in sucrose,  nuclei and cell debris were sedimented 
(600 g~v for 10 min), and the pellet was washed with 5 ml buffer containing 
0.25 M  sucrose.  The first  supernatant and the wash were combined and 
centrifuged at  10,000 gay for 20 min, yielding a  supernatant which was 
decanted and then centrifuged at 100,000 g~ for 60 min in a SW50.1 rotor 
(Beckman Instruments, Inc.) to sediment TM.  All the above steps  were 
carried out at 0-4~  The TM pellets were solubilized in SDS-PAGE sample 
buffer, and their proteins (5-10 nag) were separated  by electrophoresis in 
2-ram-thick preparative 10% slab gels and transferred to nitrocellulose. 
Immunoblotting 
Electrophoretic transfer of proteins to nitrocellulose paper (0.44 ~tm, pore 
size) was carried out at 4~  for 12-18 h at 160-200 mA according to Towbin 
et al. (37). The transferred proteins were visualized by staining with 1% 
Ponceau  S in 5% ~CA (6) followed by destaining in three brief rinses of 
10% acetic acid. The nitrocellulose  strips were quenched for 2 h in buffer 
A (50 mM Tris, pH 7.6, 200 mM NaC1, 1% Tween-20, 5 % nonfat dry milk), 
and then reacted for 2-12 h with anti-B2 IgG (20 tlg/ml) diluted in the same 
buffer. After washing with buffer B (buffer A containing only 0.1% Tween- 
20), the strips were reacted  with either ~zSI-protein A or anti-rabbit IgG 
coupled to alkaline phosphatase, diluted 1:1,000 in buffer B, washed,  and 
then either exposed  to x-ray  film or  reacted  with alkaline phosphatase 
substrate (0.1 M Tris,  pH 9.5,  100 mM NaCI,  5 mM MgCI2 containing 
5-bromo-4-chloro-3-indolyl-phosphate)  for 2-10 rain. 
A~inity Purification of  Anti-58-kD Antibodies 
Antibodies against the 58-kD protein were purified using a modification of 
the procedure described by Talian et al. (34). Briefly, proteins from a TM 
fraction of myeloma cell proteins and separated by SDS-PAGE were trans- 
ferred to nitrocellulose,  and the location of the 58-kD protein was deter- 
mined on marker strips cut from both sides of the transfer by the alkaline 
phosphatase-immunostaining  procedure.  The nitrocellulose region contain- 
ing the 58-kD protein was excised,  quenched (10% FBS,  1% BSA in PBS 
for 2 h), and reacted overnight with anti-B2 antiserum diluted 1:4 in PBS. 
After three rinses with PBS,  the bound antibodies were eluted  from the 
nitrocellulose  by two successive  treatments (15 s each) with 3 ml 0.2 M 
glycine-HCI  buffer (pH 2.8) containing 0.1% gelatin.  Elution was carried 
out in 5 ml syringes as described (34),  and the eluates were immediately 
neutralized with 1 M NaOH, dialyzed overnight against PBS, and concen- 
trated (5-10￿  using Aquacide (Calbiochem-Behring Corp.). 
lmmunofluorescence 
Nlbdg cells grown on glass coverslips  in 35-mm culture dishes were fixed 
in 3% formaldehyde  in 0.1 M Na-phosphate buffer, pH 7.2,  for 60 min as 
described previously (4). Mouse myeloma cells were similarly fixed in sus- 
pension and attached to polylysine-coated  glass slides (39). Both NRK and 
mouse myeloma cells were then permeabilized (in 0.05 % Triton X-100) and 
incubated (30 min to 12 h) with rabbit protein A-purified (50-100  ~tg/ml) 
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min). They were then examined by epifluorescenee  and photographed using 
a  Zeiss Photomicroscope III and Kodak Tri-X Pan (400 ASA) film. 
Rat pancreas was fixed for 4 h in paraformaldehyde-lysine-periodate  fixa- 
tive (23), cryoprotected in sucrose, and frozen in liquid N2 (36). Semithin 
(~0.5  ltm)  frozen  sections  were  cut  on  an  ultramicrotome  (Reichart 
Scientific Instruments, Div.  Warner-Lambert Technologies Inc., Buffalo, 
NY) equipped with a cryoattachment (36),  quenched in 50 mM NH4CI, 
and stained for immunofluorescence with anti-B2 antibodies as described 
above for cultured ceils except that the permeabilization step was omitted. 
Controls consisted of incubations in which preimmune serum was sub- 
stituted for immune serum or incubation in the first antibody was elimi- 
nated. 
Immunoperoxidase 
Staining of  mouse myeloma (RPC 5.4) cells by immunoperoxidase  and pro- 
cessing for electron microscopy was carried out as previously described 
(39). Briefly, cells were fixed in paraformaldehyde-lysine-perindate  fixative 
(4-12  h), attached to polylysine-coated glass slides, incubated in anti-B2 
IgG (100 lxg/ml) overnight, and peroxidase-conjugated Fab fragments of 
sheep anti-rabbit IgG (60 rain), followed by reaction with diaminobenzi- 
dine, and Epon embedding. Thin sections were stained with lead citrate and 
examined and photographed using either a Philips 410 or a JEOL  100CX 
electron microscope operated at 60 kV. 
Results 
Preparation and Characterization of  the Antigen 
(Steps I and 2) 
SDS-PAGE analysis of the detergent and aqueous phases of 
heavy pancreatic Golgi subfractions (B2), prepared accord- 
ing to Bordier (3), showed that this procedure efficiently (but 
not completely) separated membrane proteins from the con- 
tent and adsorbed secretory proteins that fractionated to the 
aqueous phase (data not shown). The proteins in the deter- 
gent phase were used to immunize two rabbits, which gener- 
ated two antisera referred to as anti-B2. 
Screening by Immunofluorescence on NRK 
and Mouse Myeloma Cells (Step 3) 
Since the rabbits were immunized with a mixture of proteins 
derived from B2 fractions, we expected that the antibodies 
generated would recognize specific pancreas antigens  (in- 
cluding contaminating secretory antigens) as well as Golgi- 
specific antigens. We screened several, nonpancreas cultured 
cell lines by immunofluorescence to detect general Golgi- 
specific antigens. With one of the anti-B2 IgGs, a prominent 
juxtanuclear immunofluorescence pattern corresponding to 
the location of the Golgi region was seen in both NRK (Fig. 
1 A) and mouse myeloma cells (Fig. 1, B and C). In addition 
to Golgi staining,  however, there was  also staining of the 
plasma membrane and of  small vesicles in the perinuclear re- 
gion in NRK cells, but no staining of the ER or the nuclear 
envelope was observed in either cell type. We concluded that 
this antiserum was worthy of further characterization. The 
second antiserum gave a  similar but considerably weaker 
staining pattern and was not studied further. 
When the anti-B2 IgG that gave a strong Golgi signal on 
NRK and myeloma cells was used to stain semithin sections 
of the exocrine pancreas, it also gave a strong staining of the 
Golgi region (Fig. 2, A-B). However, it reacted with the api- 
cal and basolateral plasma membranes of pancreatic cells as 
well.  These  results  indicated  that  in  pancreatic  exocrine 
cells, anti-B2 recognizes not only one or more Golgi anti- 
gens, but it also recognizes other, non-Golgi antigens. 
Figure 1. Immunofluorescence microscopy of aldehyde-fixed  NRK 
cells (A) and mouse myeloma cells (B and C) stained with anti-B2 
IgG. In both cell types there is a strong fluorescent signal in the 
Golgi region. In NRK ceils it is seen as an intensely stained cap 
located to one side of the nucleus. In myeloma cells it appears as 
a pale ringlike structure.  There is also vesicular staining in the 
perinuclear region in NRK cells. No staining of the nuclear mem- 
brane or ER is seen in either cell type. The difference in fluores- 
cence intensity and apparent resolution in the two cell types is due 
to a marked difference in cell thickness. Bar, 10 ~tm. 
Immunoelectron Microscopic  Localization 
of  the Anti-B2 IgG to cis-Golgi Cisternae of  Mouse 
Myeloma Cells (Step 4) 
To obtain  detailed information on  the  localization of the 
Golgi-specific antigens  recognized by  anti-B2  within  the 
Golgi  complex,  we  carried  out  immunocytochemistry in 
mouse myeloma (RPC 5.4) cells at the electron microscope 
level using an indirect immunoperoxidase technique.  My- 
eloma  cells were used  for this  purpose because:  (a)  the 
anti-B2 IgG exclusively gave a Golgi signal by immunofluo- 
rescence on this cell type (Fig.  1 B), and (b) these cells are 
particularly suitable for localization of  antigens among Golgi 
subcompartments since the Golgi complex is highly polar- 
ized and its sidedness (cis vs.  trans) can usually be deter- 
mined unequivocally by the presence of transitional elements 
of the ER on the cis-side of the stack (25, 39). 
After immunolabeling myeloma cells with anti-B2 IgG, 
peroxidase reaction product was found within the Golgi com- 
plex of virtually every cell. Within the Golgi complex it was 
seen  to be restricted entirely to cis elements.  In  the vast 
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~tm) cryosection prepared from aldehyde-fixed  rat pancreas. The 
section was reacted with anti-B2 IgG and photographed by phase 
contrast (A) or fluorescence (B) microscopy. Intracellular staining 
is almost completely restricted to the apical or Golgi region (ar- 
rows). In addition, both the apical and basolateral domains of the 
plasmalemma  of  the acinar cells are intensely  labeled. The contents 
of the acinar lumen (lu) and the rough ER at the base of the cell 
are not reactive. Fig. 4 A demonstrates the location of the nuclei 
(n), apical zymogen granules (gr),  and mitochondria (m). Bar, 
lima. 
majority of cells reaction product was typically confined to 
the lumina of the fenestrated, cis-most cisterna and some of 
the tubules and vesicles associated with it (Figs. 3-5), but 
in some cells partial labeling of the next (penultimate) cis 
element was also seen (Fig. 4). No staining of trans or mid- 
die cisternae was observed.  The fenestrated nature of the 
reactive cis cisterna was particularly evident in grazing sec- 
tions (Fig. 3 B), which showed that some of the reactive tu- 
bules and vesicles on the cis face of the Golgi complex were 
in continuity with the cis-most Golgi cisterna (Figs. 3 and 
4). Fig. 5 shows a panel of  labeled cis cisternae, vesicles, and 
tubules in fields in which the cis side of the Golgi complex 
is clearly marked by the presence of transitional elements of 
the rough ER. Although usually the ER cisternae, including 
the perinuclear cisternae and the transitional elements of the 
rough ER, were not immunoreactive, in 20-25 % of the cells 
some rough ER and transitional elements showed a  weak 
reaction (e.g., Fig. 5). It was concluded that anti-B2 recog- 
nizes one or more antigens that are largely restricted to cis- 
Golgi elements in myeloma cells. Similar results were ob- 
tained on anterior pituitary cells (micrographs not shown). 
Anti-B2 Recognizes Primarily a 58-kD Protein by 
Immunoprecipitation of  Biosynthetically Labeled NRK 
and Mouse Myeloma Cells (Step 5) 
The next step was to attempt to identify the cis-Golgi-spe- 
cific antigen recognized by the anti-B2 IgG. When immuno- 
precipitations were carried out on [3~S]methionine-labeled 
NRK cell lysates with anti-B2, a 58-kD protein was the ma- 
jor antigen recognized, but the antibody also reacted with 
two minor proteins (,,~35 and 85 kD). When similar immu- 
noprecipitations were done on detergent lysates of TM from 
biosynthetically labeled  myeloma  cells,  these  antibodies 
reacted with only a single major protein of 58 kD (Fig. 6 A, 
lanes 3-4). The specific reaction of anti-B2 with the 58-kD 
protein could also be demonstrated by immunoblotting on 
myeloma cell microsomes (Fig. 6 B, lane 5). These results 
indicated that the cis-Golgi-staining seen with anti-B2 was 
related to its recognition of a 58-kD protein. 
lmmunoprecipitation of  Pancreatic B2 Proteins 
with Anti-B2 
To determine whether a band corresponding in mobility to 
the 58-kD protein was recognized in pancreatic B2 mem- 
branes, immunoprecipitations were carried out with radio- 
iodinated B2 proteins recovered in the detergent phase after 
Triton X-114 separation.  The results (Fig.  6 A,  lanes 1-2) 
showed that the antibodies recognize a 58-kD band as well 
as two other major and three minor proteins. 
A~nity Purification of  Anti-58-kD IgG 
To verify that the observed reaction of the anti-B2 IgG with 
the Golgi complex was due to the recognition of the 58-kD 
protein, antibodies specifically directed against this protein 
were affinity  purified from the polyclonal antiserum by bind- 
ing them to the 58-kD myeloma cell protein which had been 
electrophoretically transferred to nitrocellulose (34).  When 
the antibodies were eluted and concentrated, they were found 
to react specifically with only the 58-kD protein in irnmuno- 
blots of myeloma cell TM (Fig. 6 B, lane 6) and pancreas 
B2 proteins (Fig. 6 B, lane 7). These results indicate that the 
anti-58-kD IgG recognizes the same 58-kD Golgi protein in 
both mouse myeloma and rat exocrine pancreatic cells, and 
that the 58-kD protein is enriched in heavy (cis) pancreatic 
Golgi subfractions. 
By immunofluorescence the affinity-purified anti-58-kD 
IgG gave a typical Golgi-type signal in aldehyde-fixed NRK 
cells and mouse myeloma cells. Moreover, they also gave a 
weak staining pattern restricted to the apical or Golgi region 
in cryostat sections of rat pancreas. Attempts were also made 
to use the affinity-purified anti-58-kD IgG to label mouse 
myeloma cells and pancreatic acinar cells by immunoelec- 
tron microscopy, but so far these attempts have not been suc- 
The Journal of Cell Biology, Volume 105,  1987  2024 Figure 3, Immunoperoxidase localization of anti-B2 antibodies in mouse myeloma RPC 5.4 cells showing that peroxidase reaction product 
is predominantly confined to the lumen of the fenestrated cis-most Golgi cisterna and to vesicles or tubules in continuity with this cis- 
terna  (arrows).  Occasionally partial  staining of the penultimate cisterna is also observed. In addition,  sometimes a tubule or vesicle 
located at some distance from the Golgi complex is also labeled. Weak peroxidase reaction is also seen in the ER (er) and in the transitional 
elements (te) (part rough, part smooth) of the ER, The inset (B) shows an oblique section through a labeled cis element (to the/eft and 
upper right),  demonstrating its fenestrated nature, pro, plasma membrane; nu, nucleus; ne, portion of the nuclear envelope; m, mitochon- 
dria;  te, transitional elements. Bar, 0.5 ~tm. 
cessful. Although the affinity-purified IgG reacted strongly 
by immunoblotting, it yielded only a weak signal on alde- 
hyde-fixed tissues by immunofluorescence and was too weak 
to be useful for immunoelectron microscopy. 
We also analyzed the distribution of the 58-kD protein in 
pancreatic subfractions by immunoblotting and found that al- 
though the 58-kD protein was detected in all subfractions 
(B2-B4), it was much more enriched in heavy (B2) as com- 
pared with light (B4) Golgi subfractions. We therefore as- 
sume  that  the  subfractions are  more extensively contami- 
nated by cis- than by trans-Golgi  elements. 
Discussion 
We have produced antibodies to membrane proteins prepared 
from a  heavy Golgi subfraction enriched in cis-Golgi  ele- 
ments. The antibodies recognize a 58-kD protein by immu- 
noprecipitation and  immunoblotting and  by  immunocyto- 
chemistry we have localized the 58-kD protein to cis-Golgi 
elements.  This  Golgi  protein  appears  to  be  widely  dis- 
tributed: our collective immunochemical and immunocyto- 
chemical results indicate that it is found in cells of diverse 
tissue origin (i.e,, mouse myeloma cells and rat kidney, exo- 
crine pancreatic, and anterior pituitary cells).  The 58-kD 
protein  is  in  all  likelihood an integral  membrane protein 
since  it  separates  virtually completely with  the detergent 
phase by the Triton X-114 procedure (3). Moreover, prelimi- 
nary lectin-binding and enzyme-digestion studies (17) sug- 
gest that it is a glycoprotein that carries both N- and O-linked 
oligosaccharides. The epitopes of the 58-kD protein recog- 
nized by anti-B2 are located largely on the ectodomain of the 
molecule, because when the antibody was localized by im- 
munoperoxidase  at  the  EM  level  reaction  product  was 
confined to the lumen of the cis-cistemae.  Further informa- 
tion on the nature and function of the 58-kD protein should 
be of  great interest since to date no cis-Golgi resident protein 
Saraste et al, Identification  of a 58-kD cis-Golgi  Protein  2025 Figure 4. Inununoperoxidase  labeling  of  the Golgi complex  ofa myeloma  cell with anti-B2 IgG shown  at higher magnification  which demon- 
strates that typically the staining is concentrated within the fenestrated  cis-most Golgi cistema (1) of the Golgi stack (G) or within vesicles 
(ve) closely associated with the cis cistema. Partial staining of the penultimate cistema (2) is also observed. The reactive cis cisternae 
are cut in normal section below and in grazing section above (arrows). Bar, 0.25 ~tm. 
has been characterized, and no reliable marker exists for this 
subcompartment of the Golgi complex. 
The Golgi complex is known to be the exclusive intracellu- 
lar site of a number of posttranslational modifications that 
secretory, membrane, and lysosomal proteins undergo dur- 
ing  their  movement  along  the  exocytic  pathway.  These 
modifications  include trimming and addition of  terminal sug- 
ars (galactose, sialic acid) to N-linked oligosaccharides, ad- 
dition of mannose-6-phosphate (Man-6-P) residues to lyso- 
somal  enzymes,  sulfation,  and  proteolytic processing  of 
some secretory proteins (8,  11,  12,  15,  19, 35).  Several en- 
zymes involved in these processing events have been  as- 
sumed to be present in cis-Golgi elements, because the cor- 
responding activities are most concentrated in heavy Golgi 
subfractions. The list includes: N-acetylglucosaminylphos- 
photransferase  and  N-acetylglucosamine-t-phosphodiester 
a-N-acetylglucosaminidase (14, 19,  26)  (the two enzymes 
that generate the Man-6-P recognition marker on lysosomal 
enzymes), as well as Golgi tt-ma~osidase I (19), and per- 
haps the enzyme(s) involved in fatty acid acylation (7,  10). 
However,  none of the above enzymes has yet been purified 
or localized by immunocytochemistry. The only successful 
purification of a putative cis-Golgi protein is that of Tulsiani 
and Touster (38), who reported in a recent abstract the isola- 
tion of Golgi a-mannosidase IA which,  interestingly, ap- 
pears on SDS gels as a doublet at 57 and 58 kD. The osmium 
reduction impregnation method (13) was used extensively in 
the past to label cis-Golgi cisternae, but the chemistry of the 
reactions involved remains unknown and the distribution of 
the reaction product varies somewhat with cell type and reac- 
tion conditions. 
The present observations, as well as previous morphologi- 
cal and cytochemical studies (reviewed in 11, 12), point to the 
existence of  considerable heterogeneity among cis-Golgi ele- 
ments. In practically all myeloma cells there is a specific and 
preferential concentration of the 58-kD protein in the cis- 
most cisterna of the stack, and the antigen is also regularly 
detected in some of  the tubules and vesicles located along the 
cis face of the Golgi complex. Such elements are known (18, 
30) to play a role in the transport of  biosynthetic  products be- 
tween the transitional elements of the ER and the cis-Golgi 
cisterna. In the majority of cells no reaction product was de- 
tected in ER cisternae and transitional elements of the ER; 
however,  weak labeling of some of these elements was de- 
tected in 20--25 % of the cells. Although the anti-B2 IgG 
recognizes only the 58-kD protein by immunoprecipitation 
The Journal of Cell Biology, Volume 105,  1987  2026 Figure 5. Four micrographs demonstrating the immunoreactivity of the cis-Golgi cistemae and of tubules and vesicles located between 
the transitional elements of the ER (te) and the cis-most Golgi cisterna with anti-B2 IgG. The stacked cisternae of the Golgi complex are 
cut normally in A, B, and C but are missed entirely in D which reveals only peripheral (cis) tubular and vesicular Golgi dements. Note 
that some of the latter are not labeled. Bar, 0.25 ~tm. 
and immunoblotting, it cannot be determined with certainty 
whether the weak labeling of a minority of the transitional 
ER elements is due to the presence of another antigenically 
related minor protein or to the occurrence of the 58-kD pro- 
tein in these elements at a low concentration. The 58-kD pro- 
tein is expected to transit from the ER to cis-Golgi cisternae 
during its biosynthesis. Further, more detailed localization 
of the 58-kD protein among cis-Golgi  elements awaits  the 
generation (now in progress) of specific monoclonal or poly- 
clonal antibodies against the purified 58-kD protein. 
There have been a few previous attempts to produce anti- 
bodies against Golgi proteins. The first successful generation 
of Golgi-specific antibodies was that of Louvard et al.  (21) 
who immunized rabbits with light Golgi subfractions pre- 
pared from rat liver and removed unwanted antibodies (e.g., 
those reacting with plasma membrane and ER) by absorption 
with  the  appropriate  membrane  fractions.  With  this  ap- 
proach they generated an antibody against a  135-kD mem- 
brane glycoprotein that specifically stains the Golgi region 
by immunofluorescence  and is broadly distributed across the 
cisternal stacks by immunoelectron microscopy. More re- 
cently, Chicheportiche et al. (5) produced a monoclonal anti- 
body against a  Golgi fraction derived from myeloma cells 
that recognizes a 54-kD peripheral membrane protein local- 
ized primarily on middle Golgi cisternae. Two other mono- 
clonals that stain Golgi elements have been generated: one 
recognizes a ll0-kD heat shock protein present in the nucleus 
as well as the Golgi complex (20), and the other recognizes 
a  103-108-kD  protein present in trans-Golgi elements (33). 
Both of the latter antibodies are IgMs and thus are of limited 
usefulness  for immunocytochemical studies.  None of the 
Golgi antibodies generated to date specifically recognizes 
cis-Golgi elements. 
In summary, we have identified a 58-kD protein that ap- 
pears to provide a  suitable marker for cis-Golgi  elements. 
Further studies now in progress are aimed at establishing the 
Saraste et al. Identification  of a 58-kD cis-Gotgi  Protein  2027 properties of the 58-kD protein, especially its function, the 
steps involved in its biosynthesis, the nature of its oligosac- 
charide moieties, and the kinetics of its  incorporation into 
the Golgi complex. 
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Figure 6.  (A) Immunoprecipitates obtained with anti-B2 antiserum 
from radioiodinated pancreas B2 proteins (lanes 1  and 2)  or bio- 
synthetically labeled myeloma cell extracts (lanes 3 and 4) showing 
that the antiserum recognizes three major bands including a 58-kD 
protein in B2 membranes (lane 2), whereas in myeloma cell extracts 
(lane  4)  it  recognizes only  a  58-kD  protein.  Lanes  1  and  3  are 
preimmune  controls.  B2  fractions  collected from  four  gradients 
were separated into membrane and content subfractions by the Tri- 
ton X-114 procedure. The proteins recovered in the detergent phase 
(•200  ~tg) were radioiodinated, aliquots of  the labeled proteins (,~l 
x  l06  cpm) were subjected to  immunoprecipitation as described 
in Materials and Methods, and the immunoprecipitates were pro- 
cessed for SDS-PAGE and fluorography. Mouse myeloma RPC 5.4 
cells,  labeled  for 4  h  with  100  I.tCi/ml  of [35Slmethionine,  were 
solubilized in lysis buffer containing  1%  Triton X-100. Aliquots of 
the cleared lysates were used in immunoprecipitation, and the im- 
munoprecipitates were analyzed by SDS-PAGE. (B) Immuneover- 
lays of myeloma TM or pancreas B2 proteins with anti-B2 or affin- 
ity-purified anti-58-kD IgG.  Myeloma TM proteins and pancreas 
B2 proteins were separated by SDS-PAGE (,~100 ttg protein/lane), 
the  proteins  were  transferred to  nitrocellulose,  and  strips  of the 
nitrocellulose were reacted with anti-B2 (lane 5) or affinity-purified 
anti-58-kD IgG (lanes 6 and 7). In myeloma cells, both the affinity- 
purified  anti-58-kD  IgG  and  the  whole  anti-B2  IgG  fraction 
specifically detect only the 58-kD  protein.  In pancreas B2 mem- 
branes,  the affinity-purified anti-58-kD  IgG  recognizes only  the 
58-kD protein (lane 7), whereas the whole IgG reacts with several 
additional bands (see lane 2). 
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